Folgen
Debapriya Basu
Debapriya Basu
NYU School of Medicine
Bestätigte E-Mail-Adresse bei nyumc.org
Titel
Zitiert von
Zitiert von
Jahr
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
JDE Philip L.S.M. Gordts, Ryan Nock, Ni-Huiping Son, Bastian Ramms,Irene Lew ...
Journal of Clinical Investigation, 2016
2582016
Endothelial cell CD36 optimizes tissue fatty acid uptake
NH Son, D Basu, D Samovski, TA Pietka, VS Peche, F Willecke, X Fang, ...
The Journal of clinical investigation 128 (10), 4329-4342, 2018
2162018
Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes
MAJ Kraakman MJ, Lee MKS, Al-Sharea A, Dragoljevic D, Barrett TJ, Montenont ...
Journal of Clinical Investigation, 2017
2082017
Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity
X Lei, F Shi, D Basu, A Huq, S Routhier, R Day, W Jin
Journal of Biological Chemistry 286 (18), 15747-15756, 2011
1622011
Mechanism of increased LDL (low-density lipoprotein) and decreased triglycerides with SGLT2 (sodium-glucose cotransporter 2) inhibition
D Basu, LA Huggins, D Scerbo, J Obunike, AE Mullick, PL Rothenberg, ...
Arteriosclerosis, thrombosis, and vascular biology 38 (9), 2207-2216, 2018
1472018
Endothelial cell receptors in tissue lipid uptake and metabolism
NA Abumrad, AG Cabodevilla, D Samovski, T Pietka, D Basu, IJ Goldberg
Circulation research 128 (3), 433-450, 2021
872021
Regulation of lipoprotein lipase-mediated lipolysis of triglycerides
D Basu, IJ Goldberg
Current opinion in lipidology 31 (3), 154-160, 2020
812020
Determination of lipoprotein lipase activity using a novel fluorescent lipase assay [S]
D Basu, J Manjur, W Jin
Journal of lipid research 52 (4), 826-832, 2011
722011
A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides
A Wolska, L Lo, DO Sviridov, M Pourmousa, M Pryor, SS Ghosh, R Kakkar, ...
Science translational medicine 12 (528), eaaw7905, 2020
692020
Novel reversible model of atherosclerosis and regression using oligonucleotide regulation of the LDL receptor
D Basu, Y Hu, LA Huggins, AE Mullick, MJ Graham, T Wietecha, ...
Circulation research 122 (4), 560-567, 2018
592018
Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models
DBKE Bornfeldt
Frontiers in Endocrinology, 2020
432020
Hepatic overexpression of the prodomain of furin lessens progression of atherosclerosis and reduces vascular remodeling in response to injury
X Lei, D Basu, Z Li, M Zhang, RD Rudic, XC Jiang, W Jin
Atherosclerosis 236 (1), 121-130, 2014
242014
Lipolytic enzymes and free fatty acids at the endothelial interface
IJ Goldberg, AG Cabodevilla, D Samovski, V Cifarelli, D Basu, ...
Atherosclerosis 329, 1-8, 2021
212021
Atherosclerosis regression and cholesterol efflux in hypertriglyceridemic mice
T Josefs, D Basu, T Vaisar, B Arets, JE Kanter, LA Huggins, Y Hu, J Liu, ...
Circulation research 128 (6), 690-705, 2021
212021
Angiopoietin-like 3: an important protein in regulating lipoprotein levels
KH Burks, D Basu, IJ Goldberg, NO Stitziel
Best Practice & Research Clinical Endocrinology & Metabolism 37 (3), 101688, 2023
152023
CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins
M Shimizu-Albergine, D Basu, JE Kanter, F Kramer, V Kothari, S Barnhart, ...
The Journal of Clinical Investigation 131 (22), 2021
152021
Measurement of the phospholipase activity of endothelial lipase in mouse plasma
D Basu, X Lei, J Josekutty, MM Hussain, W Jin
Journal of Lipid Research 54 (1), 282-289, 2013
132013
Hepatic S1P deficiency lowers plasma cholesterol levels in apoB-containing lipoproteins when LDLR function is compromised
D Basu, A Huq, J Iqbal, MM Hussain, XC Jiang, W Jin
Nutrition & Metabolism 12, 1-14, 2015
82015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–18